Nov 13, 2024, 08:41 AM by

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.

Nov 13, 2024, 08:41 AM by

CG Life, a leading integrated agency that blends strategy, creative, marketing, digital, and communications with science, has welcomed Allison Davis to the agency’s newly created role of Chief Client Officer.

Nov 13, 2024, 01:00 AM by User Not Found

Bio-IT World | The spliceosome, the cellular machinery that catalyzes the process of splicing in genes, was discovered nearly five decades ago and has been successfully leveraged in the development of therapies for rare diseases such as spinal muscular dystrophy where concerns about side effects tend to be secondary to correcting the underlying pathology. The question now is how to move the strategy to more complex diseases involving more than a single gene and splicing mutation.

Nov 12, 2024, 08:16 AM by

Rousselot, Darling Ingredients’ premier collagen and gelatin brand, and IamFluidics, a leader in microparticle innovation, today announced the launch of a novel research grade dissolvable microcarrier for adherent cell culturing. The product is designed to streamline and scale-up processes for advanced cell therapies, biologics manufacturing and cultured meat production.

Nov 12, 2024, 08:16 AM by

MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.

Nov 12, 2024, 08:16 AM by

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients. This breakthrough enables precise segmentation of DKD patients by disease trajectory over time, marking a pivotal advancement in precision medicine for DKD. MultiOmic’s CEO Robert Thong will present these findings at the LSX Investival Conference in London on 18th November 2024.

Nov 12, 2024, 08:16 AM by

Nov 12, 2024, 01:00 AM by User Not Found

Bio-IT World | In recent research, scientists at the University of Arizona have developed a diagnostic tool, the MeCo Score, which evaluates metastatic risk in early-stage breast cancer by analyzing how cancer cells respond to the stiffness of surrounding tissue. This tool leverages RNA sequencing data from tumor samples to identify a "mechanical conditioning" (MeCo) signature, giving insights into cancer cell adaptations within the tumor microenvironment.

Nov 11, 2024, 08:25 AM by

AppOmni, the leader in SaaS security today announced a significant partnership that combines the company’s Zero Trust Posture Management (ZTPM) solution with Cisco’s Security Service Edge (SSE) technology suite to enable zero trust principles at the application layer in Security-as-a-Service (SaaS) applications.

Nov 8, 2024, 01:00 AM by User Not Found

Bio-IT World | For AI and data-driven drug discovery to have a tangible impact on R&D success, a change in the culture is as important as any investment at a data, model, and validation level. Until quite recently, the perceived value of AI in drug discovery and development failed to match the hype.

Nov 7, 2024, 10:45 AM by

UK-based pharma strategic consultancy, The MAP Group has acquired market access and pricing consultancy, SKC Beratungsgesellschaft mbH as it continues to expand internationally.

Nov 7, 2024, 01:00 AM by User Not Found

Bio-IT World | This week at the American Society of Human Genetics meeting, Pacific Biosciences unveiled both its new SPRQ chemistry—pronounced “spark”— and its newest sequencing platform, Vega, a desktop, long-read sequencer with all the compute on board. Also it’s pink.

Nov 6, 2024, 08:27 AM by

Oxford Nanopore announced a landmark strategic partnership that brings together Genomics England, UK Biobank, and NHS England to enable genomics-based translational research and accelerate the development and adoption of Oxford Nanopore’s ground-breaking genomics technology in the NHS.

Nov 4, 2024, 08:55 AM by

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider of integrated, pre-clinical drug discovery services, today announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services using the technology.

Nov 4, 2024, 01:00 AM by User Not Found

Bio-IT World | The traditional LDL and HDL cholesterol tests may soon be obsolete as new research suggests they provide an incomplete view of heart health compared to other lipid molecules circulating in the blood. This shift stems from a recent study led by Dr. Cristina Legido-Quigley, a systems medicine expert at King’s College London and Steno Diabetes Centre, which analyzed lipids in children with obesity.

Nov 1, 2024, 08:05 AM by

Endor Labs, the leader in open source software security, has once again been selected to the prestigious Fortune Cyber 60 list, the second consecutive year it has received this recognition.

Nov 1, 2024, 08:05 AM by

PathAI, a leader in digital and AI-powered pathology solutions, and VIZIA Diagnostics, a GI- specialized pathology laboratory based in Alpharetta, Georgia, have announced that VIZIA has adopted PathAI’s AISightⓇ1 Image Management System (IMS) and AI technology to advance the precision and operational efficiency of its pathology services.

Nov 1, 2024, 08:05 AM by

Nov 1, 2024, 08:05 AM by

Nov 1, 2024, 08:05 AM by